End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,550 KRW | +0.18% | +0.35% | +2.88% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Business Summary
Number of employees: 553
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
SAP Products
77.6
%
| 141,157 | 76.6 % | 151,202 | 77.6 % | +7.12% |
Ampoule and Vial
21.5
%
| 40,120 | 21.8 % | 41,844 | 21.5 % | +4.30% |
Other
0.6
%
| 2,225 | 1.2 % | 1,074 | 0.6 % | -51.73% |
Testing and Inspection
0.4
%
| 765 | 0.4 % | 791 | 0.4 % | +3.40% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 184,268 | 100.0 % | 195,911 | 100.0 % | +6.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 69-06-30 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 02-02-28 |
Seong-Soo Yoon
AUD | Comptroller/Controller/Auditor | 46 | 17-03-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 69-06-30 |
Seung-Young Lee
BRD | Director/Board Member | 51 | 02-02-28 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 02-02-28 |
Geon-Seok Seo
BRD | Director/Board Member | 82 | 17-03-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,000,000 | 3,559,472 ( 59.32 %) | 120,000 ( 2.000 %) | 59.32 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
120,000 | 2.00% | 2,522,563 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.88% | 124M | |
+20.32% | 43.95B | |
+21.52% | 22.49B | |
+11.68% | 14.71B | |
+11.31% | 13.77B | |
+42.32% | 12.3B | |
-8.98% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.48B |
- Stock Market
- Equities
- A023910 Stock
- Company Daihan Pharmaceutical Co.,Ltd.